Hicks Laurence 4
4 · Arch Therapeutics, Inc. · Filed Oct 13, 2021
Insider Transaction Report
Form 4
Hicks Laurence
Director
Transactions
- Award
Stock Option (right to buy)
2021-09-27+250,000→ 250,000 totalExercise: $0.10Exp: 2031-09-26→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The option was granted pursuant to the Issuer's 2013 Stock Incentive Plan (the "Plan"). The option shall vest equally on each of the first 36 month anniversaries of the grant date, subject to continued service to the Issuer through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), 100% of the number of unvested shares then subject to the option shall accelerate and become immediately exercisable.